%0 Journal Article
%T Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
%A Esteban J¨Ždar
%A Ildiko Lingvay
%A Ingrid Holst
%A Irene Hramiak
%A Lawrence A. Leiter
%A Sten Madsbad
%A Stephen C. Bain
%A Theis Gondolf
%A Thomas Hansen
%J Archive of "Cardiovascular Diabetology".
%D 2019
%R 10.1186/s12933-019-0871-8
%X The online version of this article (10.1186/s12933-019-0871-8) contains supplementary material, which is available to authorized users
%K Semaglutide
%K Cardiovascular events
%K Gender
%K Age
%K Baseline cardiovascular risk
%K Type 2 diabetes
%K SUSTAIN 6
%K Cardiovascular outcome trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551895/